Weill Medical College of Cornell University

• Home
• The New York Brain Tumor Center
• Clinical Neuro-Oncology Program
• Brain Tumor Research Group
• Skull Base Lab
• Neuro-Oncology Active Clinical Trials List
• The Pituitary & Anterior Skull Base Surgery Program
• Program Faculty
• Conditions Treated
• Adult Pituitary Treatment
• In The News
• Pediatric Brain and Spinal Cord Tumors
• Skull Base Surgery
• Radiosurgery Program: Gamma Knife
• Stereotactic Radiosurgery
• External Beam Therapy
• Gamma Knife
• LINAC
• X-Knife
• CyberKnife

Pediatric Brain and Spinal Cord Tumors

Weill Cornell's Pediatric Brain Tumor Program incorporates many specialties directed by highly trained clinicians in specific areas of expertise. From the moment of diagnosis, a program teammost often a neurologist, radiation therapist, neuroendocrinologist, and oncologistjoin the neurosurgeon in selecting and managing the most effective combination of therapies for each patient. The team is committed to maximizing the impact of treatment while reducing potential risks so that young patients can have an optimal prognosis fornormal growth, sexual maturity and cognitive performance.

At Weill Cornell, advanced drug therapies are being used in a study for children with malignancies of the central nervous system. In addition, studies are currently being conducted on novel approaches to treatment of pediatric tumors.

Minimally Invasive Neurosurgery

Minimally invasive neurosurgery at Weill Cornell is an advanced program in existence for over a decade. Extensive experience in this technology has earned Weill Cornell national recognition as a center of excellence in minimally invasive surgery for the treatment of intraventricular brain tumors. An integral part of minimally invasive techniques is integrated stereotactic guidance, an advanced imaging system used during a surgical procedure to select the least invasive routes and minimize trauma to surrounding brain.

Pediatric Neuro-Oncology

Weill Cornell's pediatric neuro-oncology group is studying the hormonal and reproductive effects of brain tumors and their treatment. Additional studies are underway on the neuroendocrine aspects of pediatric brain tumors. In collaboration with New York University, studies are focusing on treatment outcomes in children with germ cell tumors. The studies are examining the effects of high-dose chemotherapy with bone marrow reconstitution for pediatric patients with recurrent germ cell tumors; and chemotherapy for patients with newly diagnosed germ cell tumors of the central nervous system. At Weill Cornell, radio-labeled monoclonal antibodies are being used in a study for children with disseminated malignancies of the central nervous system. In addition, studies are being conducted on local delivery systems to treat pediatric tumors.